CASIMERSEN vs CASIRIVIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CASIMERSEN vs CASIRIVIMAB: Safety Overview
| Metric | CASIMERSEN | CASIRIVIMAB |
|---|---|---|
| Total FAERS Reports | 767 | 500 |
| Deaths Reported | 7 | 24 |
| Death Rate | 0.9% | 4.8% |
| Hospitalizations | 87 | 209 |
| Average Patient Age | 14.0 yrs | 58.9 yrs |
| % Female Patients | 0.4% | 52.4% |
| FDA Approval Date | Feb 25, 2021 | N/A |
| Manufacturer | Sarepta Therapeutics, Inc. | N/A |
| Marketing Status | Prescription | N/A |